-
Following a priority review, the FDA has approved deferasirox, the first oral iron chelator for the treatment of chronic iron overload due to transfusions. It will be marketed by Novartis Pharmaceuticals as Exjade®.
-
Patients who receive extended anticoagulation are protected from recurrent VTE while receiving long-term therapy. The clinical benefit is maintained after anticoagulation is discontinued, but the magnitude of the benefit is less pronounced.
-
Beta-Blockers Therapy for the Treatment of Hypertension; Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions
-
Tipranavir is a recently approved protease inhibitor for the treatment of HIV-1 infections. It is a selective non-peptide HIV-1 protease inhibitor for treatment-experienced adults with resistance to multiple protease inhibitors. Tipranavir is marketed by Boehringer Ingelheim as Aptivus®.
-
Cola consumption, but not caffeine per se, was associated with increased risk of developing hypertension over a 12-year period.
-
Doxycycline Hyclate 20 mg Tablets and Metronidazole 0.75% Topical Lotion in the Treatment of Rosacea; Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation; Comorbid Depression with Mortality in Patients with DM
-
A new injectable diabetes medication in the family of incretin mimetic drugs has been shown to be as effective as insulin in controlling average blood sugars in Type 2 diabetics who are difficult to control on oral medications, without as much associated weight gain.
-
A meta-analysis comparing percutaneous balloon angioplasty alone vs coronary artery bypass grafting (CABG) demonstrated no significant differences in mortality and nonfatal myocardial infarction (MI) however, a statistically significant benefit in terms of survival in favor of surgery1 was noted.
-
Imiquimod is safe and effective in the treatment of actinic keratoses.
-
Should Empiric Treatment be Given to women with UTI Sx but negative U/A?; Is Routine Fundoscopy Worth the Bother in Hypertension?; Autoantibody Signatures in Prostate Cancer